Yakoubi Afef, Dhafer Cyrine El Baher
Laboratory of Hetero-organic Compounds and Nanostructured Materials, Chemistry Department, Faculty of Sciences Bizerte, University of Carthage, LR 18 ES11, 7021 Bizerte, Tunisia.
Chemistry Department College of Science, Jouf University, P.O Box: 2014, Sakaka, Saudi Arabia.
Plasmonics. 2023;18(1):311-347. doi: 10.1007/s11468-022-01754-0. Epub 2022 Dec 23.
Coronavirus is an ongoing global pandemic caused by severe acute respiratory syndrome coronavirus 2. Coronavirus disease 2019 known as COVID-19 is the worst pandemic since World War II. The outbreak of COVID-19 had a significant repercussion on the health, economy, politics, and environment, making coronavirus-related issues more complicated and becoming one of the most challenging pandemics of the last century with deadly outcomes and a high rate of the reproduction number. There are thousands of different types - or variants - of COVID circulating across the world. Viruses mutate all the time; it emphasizes the critical need for the designing of efficient vaccines to prevent virus infection, early and fast diagnosis, and effective antiviral and protective therapeutics. In this regard, the use of nanotechnology offers new opportunities for the development of novel strategies in terms of prevention, diagnosis, and treatment of COVID-19. This review presents an outline of the platforms developed using plasmonic nanoparticles in the detection, treatment, and prevention of SARS-CoV-2. We select the best strategies in each of these approaches. The properties of metallic plasmon NPs and their relevance in the development of novel point-of-care diagnosis approaches for COVID-19 are highlighted. Also, we discuss the current challenges and the future perspectives looking towards the clinical translation and the commercial aspects of nanotechnology and plasmonic NP-based diagnostic tools and therapy to fight COVID-19 pandemic. The article could be of significance for researchers dedicated to developing suitable plasmonic detection tools and therapy approaches for COVID-19 viruses and future pandemics.
冠状病毒病是由严重急性呼吸综合征冠状病毒2引起的一场持续的全球大流行。2019冠状病毒病(COVID-19)是二战以来最严重的大流行。COVID-19的爆发对健康、经济、政治和环境产生了重大影响,使冠状病毒相关问题更加复杂,并成为上世纪最具挑战性的大流行之一,导致了致命后果和高繁殖数。全球有数千种不同类型——即变体——的COVID在传播。病毒一直在变异;这凸显了设计有效疫苗以预防病毒感染、早期快速诊断以及有效的抗病毒和保护性治疗方法的迫切需求。在这方面,纳米技术的应用为开发针对COVID-19的预防、诊断和治疗新策略提供了新机遇。本综述概述了利用等离子体纳米颗粒开发的用于检测、治疗和预防严重急性呼吸综合征冠状病毒2(SARS-CoV-2)的平台。我们在这些方法中各自选择了最佳策略。强调了金属等离子体纳米颗粒的特性及其在开发针对COVID-19的新型即时诊断方法中的相关性。此外,我们讨论了当前的挑战以及纳米技术和基于等离子体纳米颗粒的诊断工具及疗法用于抗击COVID-19大流行的临床转化和商业方面的未来前景。这篇文章对于致力于为COVID-19病毒及未来大流行开发合适的等离子体检测工具和治疗方法的研究人员可能具有重要意义。
Heliyon. 2021-4
Acc Mater Res. 2022-1-12
ACS Nano. 2020-6-10
J Nanobiotechnology. 2020-9-5
Expert Rev Anti Infect Ther. 2022-10
Int Rev Immunol. 2023
Sheng Wu Gong Cheng Xue Bao. 2020-4-25
Pharmaceutics. 2024-8-23
Front Chem. 2023-7-6
J Therm Spray Technol. 2021
Trans Indian Natl Acad Eng. 2020
Sens Biosensing Res. 2021-8
J Chem Health Saf. 2021-4-16
Front Cell Infect Microbiol. 2021
J Med Virol. 2022-4
Sensors (Basel). 2021-11-24